When Does a Diagnosis Truly Begin? Kerala High Court Clarifies Insurance 'Waiting Period' Rules

In a significant ruling concerning insurance policy interpretation, the Kerala High Court has overturned a Single Judge’s decision regarding the definition of a clinical "diagnosis." The Division Bench, comprising Mr. Justice Anil K. Narendran and Mr. Justice Muralee Krishna S., held that the insurance "waiting period" is triggered by the initial clinical findings of a disease, rather than the subsequent laboratory confirmation.

The Backdrop: A Dispute Over Timeline

The case involved Haripreetha T., who had obtained a "Cancer Cover" policy from the Life Insurance Corporation of India (LIC) on March 16, 2021. The policy mandate included a 180-day waiting period from the date of issuance; if an insured person were diagnosed with cancer during this window, the policy would terminate and no benefits would be payable.

In August 2021—within 180 days of the policy start—the respondent was hospitalized with profuse bleeding. Diagnostic imaging and initial hospital assessments pointed toward endometrial malignancy. However, the formal histopathological report confirming the "Carcinoma Endometriosis" was not generated until September 28, 2021, falling just outside the 180-day mark.

Following a denied claim by LIC and a failed petition before the Insurance Ombudsman, the respondent moved the High Court. A Single Judge initially sided with the petitioner, reasoning that the disease was only "confirmed" upon receipt of the biopsy report.

Arguments from the Bench

The appellant, LIC, maintained that the policy's terms were clear: the waiting period applies to "any stage of cancer" identified on or after the policy issuance. They argued that the ultrasound and initial clinical findings on August 25, 2021, constituted a diagnosis of the illness, regardless of the retrospective confirmation by a biopsy.

The respondent contended that a "diagnosis" within the technical meaning of the policy could only be finalized by an expert after a surgical procedure and histopathological examination. They argued that until that point, the finding was merely preliminary or "suggestive."

Key Observations

The High Court emphasized that the nature of medical diagnosis is cumulative, with later tests often providing validation for initial clinical observations. In its judgment, the Court noted:

> "This shows that the final opinion arrived at by the pathology report dated 28.09.2021 is the confirmation of the diagnosis made in [the initial documents]. This diagnosis, done on 28.09.2021, is the confirmation by an expert, and it is not the first date on which cancer has been diagnosed."

Rejecting the argument that the definition of diagnosis required the final report, the Court observed:

> "The diagnosis forms the basis of patient care... It can only be said that the diagnosis of cancer was within the waiting period of 180 days. Therefore, the 1st respondent is not entitled for the policy coverage as rightly contended by the appellant."

Final Decision and Implications

The Division Bench allowed the appeal, set aside the order of the learned Single Judge, and dismissed the writ petition. The ruling confirms that for the purposes of insurance contract interpretation, an insured cannot rely on the date of final laboratory verification to bypass contractual waiting periods if the illness was clinically identified and recorded during that period.

This decision serves as a stern reminder to policyholders that insurance contracts are governed by the strict letter of their clauses. For practitioners and consumers, it underscores that "diagnosis" in litigation often carries a broader, clinical context that precedes formal diagnostic confirmation. Future claims involving "waiting periods" will likely be scrutinized based on the date of the earliest medical records indicating the onset of the condition, rather than the date of the final report.